Clinical protocols to monitor efficacy of [ 177 Lu]Lu-PSMA radiopharmaceutical therapy in metastatic castration-resistant prostate cancer.
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2025.43.5_suppl.39
Abstract: 39 Background: To assess the prognostic value of post-therapy [ 177 Lu]Lu-PSMA (LuPSMA)-SPECT/CT by visual RECIP 1.0 during LuPSMA radioligand therapy and to develop an evidence-based clinical protocol to monitor efficacy to LuPSMA. Methods: Patients… read more here.
Keywords: monitor efficacy; therapy; lupsma spect; 177 psma ... See more keywords